October 3, 2024
Overweight is a major contributor to complications during pregnancy and childbirth -- this applies to both women born in Sweden and women who have moved here, something that has not been well researched so far. Interventions that promote a healthy weight have the potential to prevent complications for all women, the researchers conclude. The study was conducted by researchers at Link ping University and Karolinska Institute and is published in The Lancet Public Health.
Body weight is an important health factor in pregnancy -- regardless of country of birth
October 3, 2024
A rare collection of 300-year-old petitions gives voice to the forgotten women who cared for England's most vulnerable children while battling their local authorities.
Early foster care gave poor women power, 17th-century records reveal
October 3, 2024
Researchers have identified a new potential risk marker for cardiovascular disease in women. A new study shows an association between low levels of an anti-inflammatory antibody and the risk of heart attack and coronary heart disease.
New cardiovascular disease risk marker discovered in older women
October 2, 2024
Global evidence has revealed that women's environmental quality of life is key to their overall quality of life and health, according to a new study.
October 2, 2024
Climate change-related landslides, storms and floods are associated with intimate partner violence against women two years after the event, according to a new study.
Storms, floods, landslides associated with intimate partner violence against women two years later
October 2, 2024
Researchers have found a potential new way to improve the treatment of multiple sclerosis (MS) using a novel combined therapy. The results build on two harmonized Phase I clinical trials, focusing on the use of Vitamin D3 tolerogenic dendritic cells (VitD3-tolDCs) to regulate the immune response in MS patients. The team is now preparing to move into Phase II trials to further explore these findings.
New study finds a promising combined therapy for multiple sclerosis
October 1, 2024
Researchers say that in the course of developing a new model for ovarian cancer, they've developed additional evidence that serous uterine cancer possibly begins in the fallopian tubes, not the uterus.
Scientist develops new model for ovarian cancer -- with crossover to uterine cancer
October 1, 2024
Researchers have made a significant step towards enabling women with epilepsy safer access to a common and highly effective anti-seizure medication. Sodium Valproate or valproic acid is widely prescribed for epilepsy and certain mental health conditions, but is considered harmful to use during pregnancy because of links to spinal cord defects and other complications for newborns. A team of organoid experts have identified a drug that may nullify the dangerous side effects.
Lab-grown spines unlock safer treatment for women with epilepsy, study suggests
October 1, 2024
A greater proportion of women in our study had EHR documentation of bothersome menopause symptoms than those reported in other studies, but vasomotor symptoms remain generally untreated. We need better methods for identifying midlife women with bothersome menopause symptoms in primary care clinics so that appropriate treatment options, including hormone therapy, can be discussed and offered.
Addressing menopause symptoms in the primary care setting: opportunity to bridge care delivery gaps
September 25, 2024
New study shows that the lengths of menstrual cycles, follicular phases (before egg release) and luteal phases (after ovulation) are all variable. The luteal phase is importantly more variable than currently believed.
Menstrual cycle luteal phase lengths are not 'fixed' at 13-14 days
